<DOC>
	<DOCNO>NCT00454389</DOCNO>
	<brief_summary>The objective CABERNET Trial evaluate safety efficacy focal delivery radiation treatment subfoveal choroidal neovascularization ( CNV ) associate wet age-related macular degeneration ( AMD ) . The Epi-Rad90™ Ophthalmic System treat neovascularization retinal tissue mean focal , directional delivery radiation target tissue retina . Using standard vitreoretinal surgical technique , seal radiation source place temporarily retinal lesion mean handheld medical device .</brief_summary>
	<brief_title>A Study Strontium90 Beta Radiation With Lucentis Treat Age-Related Macular Degeneration</brief_title>
	<detailed_description>Therapeutic advance arena neovascular age-related macular degeneration ( AMD ) provide multiple treatment option disease . Radiotherapy study multiple clinical trial past many study show therapeutic benefit . Treatment radiotherapy anti-VEGF compound promise approach treat AMD .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Subjects must predominantly classic , minimally classic , occult classic lesion , determine Investigator , secondary AMD , total lesion size ( include blood , scar , neovascularization ) &lt; 12 total disc area ( 21.24 mm2 ) , GLD ≤5.4 mm Subjects must age 50 old Subjects prior concurrent subfoveal CNV therapy include thermal laser photocoagulation ( without photographic evidence ) , photodynamic therapy , injection Macugen® , intravitreal subretinal steroid , transpupillary thermotherapy ( TTT ) , systemic antiangiogenic intravitreal antiangiogenic agent study eye . ( Note : This include subject know history , photographic evidence prior therapy ) Subjects underwent previous radiation therapy eye , head neck Subjects previously diagnose retinal finding consistent Type 1 Type 2 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Macular</keyword>
	<keyword>Degeneration</keyword>
	<keyword>AMD</keyword>
	<keyword>Wet Age-Related macular degeneration</keyword>
</DOC>